Volume 13, No 4 (2024)
Mini Review
COSTS INCURRED BY SUPPLY CHAINS AND DRUG RESISTANCE AS A RESULT OF TREATMENT HETEROGENEITY
Abstract HTML PDF
DOI: 10.37421/2277- 1506.2024.13.376
1-3
Mini Review
DRUG RESISTANCE MAY ACCELERATE AN HIV EPIDEMIC AS SHOWN BY THE NESTED MODEL
Abstract HTML PDF
DOI: 10.37421/2277- 1506.2024.13.377
1-4
Perspective
DRUG RESISTANCE, TUMOR CELL HETEROGENEITY AND EPIGENETIC MECHANISMS IN TUMORIGENESIS
HTML PDF
DOI: 10.37421/2277- 1506.2024.13.378
1-3
Opinion
FAILURE OF LYSOSOMOTROPIC DRUGS TO BE REPURPOSED FOR COVID-19 PREVENTION OR TREATMENT
HTML PDF
DOI: 10.37421/2277- 1506.2024.13.379
1-3
Commentary
RECENT HIGHLIGHTS IN RESISTANCE AND DRUG DEVELOPMENT AGAINST PROTOZOA
HTML PDF
DOI: 10.37421/2277- 1506.2024.13.380
1-3
Mini Review
INVESTIGATING DRUG RESPONSE ASSAY'S POTENTIAL FOR PRECISION THERAPY IN OVARIAN CANCER
Abstract HTML PDF
DOI: 10.37421/2277-1506.2024.13.381
1-3
Mini Review
OPIOID RECEPTOR EXPRESSION IN IMMUNE SYSTEM CELLS
Abstract HTML PDF
DOI: 10.37421/2277-1506.2024.13.382
1-3
Opinion
TUFTING ENTEROPATHY AT BIRTH: MECHANISMS, PATHOGENESIS, AND BIOLOGY
HTML PDF
DOI: 10.37421/2277- 1506.2024.13.383
1-3